Evidence map›Paper›PMID 38234268›Full record

ArticleChemical communications (Cambridge, England)2024

α-Aryl substituted GdDOTA derivatives, the perfect contrast agents for MRI?

Karley B Maier, Lauren N Rust, Fabio Carniato, Mauro Botta, Mark Woods

Abstract read
In one paragraph

Article in Chemical communications (Cambridge, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Karley B MaierDepartment of Chemistry, Portland State University, 1719 SW 10th Ave, Portland, OR, 97201, USA. mark.woods@pdx.edu.ORCID http://orcid.org/0000-0001-8573-2873
Lauren N RustDepartment of Chemistry, Portland State University, 1719 SW 10th Ave, Portland, OR, 97201, USA. mark.woods@pdx.edu.ORCID http://orcid.org/0000-0001-8585-466X
Fabio CarniatoDipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale "Amedeo Avogadro", Alessandria I-15121, Italy. mauro.botta@uniupo.it.ORCID http://orcid.org/0000-0002-6268-1687
Mauro BottaDipartimento di Scienze e Innovazione Tecnologica, Università del Piemonte Orientale "Amedeo Avogadro", Alessandria I-15121, Italy. mauro.botta@uniupo.it.ORCID http://orcid.org/0000-0003-4192-355X
Mark WoodsDepartment of Chemistry, Portland State University, 1719 SW 10th Ave, Portland, OR, 97201, USA. mark.woods@pdx.edu.ORCID http://orcid.org/0000-0003-4890-7544

Funding

Updating Bifunctional Chelators to Keep Pace with Modern Biomedical SciencesR21GM127964 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI WOODS, MARK · 2019 to 2020
$353k
Safer Metal Based Imaging AgentsR03EB034082 · NIBIB · PORTLAND STATE UNIVERSITY · PI WOODS, MARK · 2022 to 2023
$139k
NIBIB NIH HHS R03 EB034082NIGMS NIH HHS R21 GM127964
6 · The paper itself

Abstract

Enhancing the performance of Gd

Indexed as

Contrast MediaGadoliniumChelating AgentsHumansMagnetic Resonance ImagingSerum Albumin, HumanChelating AgentsContrast MediaGadoliniumSerum Albumin, Human

Identifiers

PMID38234268
PMCPMC10919327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.